Genasense (oblimersen)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Genasense (oblimersen), covering 2014-01-06 to 2014-01-06. Get the full timeline:
Most recent: Clinical Trial Update: Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 3]